Frontier Zdravlje and Adalvo Sign Licensing & Supply Agreement for Central & Eastern Europe
Frontier Zdravlje and Adalvo are pleased to announce their collaboration in several therapeutic areas for the markets of Central and Eastern Europe and the Balkans. Over the next months and years, this collaboration will extend Frontier’s commercial and therapeutic footprint with a basket of more than 30 molecules from Adalvo’s advanced development pipeline in high value chronic and niche areas, targeting early-launch and first-generic opportunities where available.
Frontier Zdravlje Awarded for Successful Business in 2022 by the Chamber of Commerce and Industry of Serbia
We are proud to announce that Frontier Zdravlje has received the Award for Successful Business in 2022 by the Chamber of Commerce and Industry of Serbia. At the Ceremony held on 9 December, the Chamber of Commerce and Industry of Serbia awarded the traditional Annual Awards to the most successful companies in Serbia.
Frontier Zdravlje at “Serbia Business Run” in Belgrade
Frontier Zdravlje participated for the first time on September 29. at the great “Serbia Business Run“ in Belgrade. This manifestation, which aims to promote healthy lifestyles and running as a great way of recreation for the modern working person, is a series of 5 km business races, which are held in the largest business centers of Serbia and represent the largest sports and corporate event in our country.
Tsvetomir Yordanov joins Frontier Zdravlje as Group Business Development Director
Frontier Zdravlje is pleased to announce that as of 1st September 2022, Mr. Tsvetomir Yordanov has joined our senior management team as Group Business Development Director, directly reporting to Kiren Naidoo (CEO).
Frontier Zdravlje receives an EU Wholesale Distribution Authorization by BDA
We are pleased to announce that as of 16 August Zdravlje Pharmaceuticals (Bulgaria), a subsidiary of Frontier Zdravlje, has received a Wholesale Distribution Authorization by the Bulgarian Drug Agency (BDA).
The ALIMS Approves Regkirona for Serbia with Frontier Zdravlje as MA Holder
The Serbian Agency for Medicines (ALIMS) has approved on 02.08.2022 the Marketing Authorisation for Regkirona (regdanvimab) for Serbia with Frontier Zdravlje as the Marketing Authorisation Holder.
Frontier Zdravlje Signs License Agreement with Medicines Patent Pool for nirmatrelvir
Frontier Zdravlje announces the signing of a license agreement with the Medicines Patent Pool (MPP) for a generic version of nirmatrelvir, the novel oral COVID-19 antiviral medicine (PF-07321332) developed by Pfizer, which is administered in combination with low dose ritonavir (PF-07321332; ritonavir). This sub-license agreement is the outcome of a licensing agreement signed between MPP and Pfizer in November 2021 to facilitate affordable global access to nirmatrelvir; ritonavir.
Successful visit supporting the World Pharmacy Students Exchange Program
As part of the World Exchange Program of Pharmacy and Pharmaceutical Sciences Students (SEP) and the International Pharmacy Students Federation (IPSF) project, which this year marks the 70th anniversary of the first successfully held exchange, Frontier Zdravlje, in coordination with the National Association of Pharmacy Students of Serbia, realized a visit of the group of 11 pharmacy students from France, Poland and Serbia.
Tamara Vasojevic joins Frontier Zdravlje as Group Human Resources Director
Tamara was most recently HR Director at Dr. Max Pharmacy Chain in Serbia and prior to that she held HR roles at Delta Holding. We are confident that the experiences gained at these companies will support Frontier Zdravlje’s further expansion locally and internationally.
Zdravlje continues with “Cap for Handicap”
Frontier Zdravlje continues its several-years’ activity aimed to support persons with disabilities as a partner to the “Cap for Handicap” Association.